These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15280092)

  • 1. Pathophysiology of stroke in sickle cell disease.
    Hillery CA; Panepinto JA
    Microcirculation; 2004 Mar; 11(2):195-208. PubMed ID: 15280092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological soft signs as the stroke risk in sickle cell disease.
    Melek I; Akgul F; Duman T; Yalcin F; Gali E
    Tohoku J Exp Med; 2006 Jun; 209(2):135-40. PubMed ID: 16707855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral vasculopathy in children with sickle cell anemia.
    Fasano RM; Meier ER; Hulbert ML
    Blood Cells Mol Dis; 2015 Jan; 54(1):17-25. PubMed ID: 25294561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle red cell microrheology and sickle blood rheology.
    Ballas SK; Mohandas N
    Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.
    Pegelow CH; Wang W; Granger S; Hsu LL; Vichinsky E; Moser FG; Bello J; Zimmerman RA; Adams RJ; Brambilla D;
    Arch Neurol; 2001 Dec; 58(12):2017-21. PubMed ID: 11735775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and treatment of stroke in sickle-cell disease: present and future.
    Switzer JA; Hess DC; Nichols FT; Adams RJ
    Lancet Neurol; 2006 Jun; 5(6):501-12. PubMed ID: 16713922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium.
    Zhou Z; Thiagarajan P; Udden M; Lòpez JA; Guchhait P
    Thromb Haemost; 2011 Jun; 105(6):1046-52. PubMed ID: 21437360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo studies of sickle red blood cells.
    Kaul DK; Fabry ME
    Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.
    Prussien KV; Jordan LC; DeBaun MR; Compas BE
    J Pediatr Psychol; 2019 Sep; 44(8):948-958. PubMed ID: 31050352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the pathophysiology and development of novel therapies for sickle cell disease.
    Moerdler S; Manwani D
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):493-506. PubMed ID: 30504350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.
    Carpenter JL; Nickel RS; Webb J; Khademian Z; Speller-Brown B; Majumdar S; Darbari DS; Campbell A; Zhang A; Abraham A
    Transplant Cell Ther; 2021 Dec; 27(12):1018.e1-1018.e9. PubMed ID: 34530179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion under flow.
    Ley K
    Microcirculation; 2009 Jan; 16(1):1-2. PubMed ID: 19191171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher prevalence of spontaneous cerebral vasculopathy and cerebral infarcts in a mouse model of sickle cell disease.
    Hyacinth HI; Sugihara CL; Spencer TL; Archer DR; Shih AY
    J Cereb Blood Flow Metab; 2019 Feb; 39(2):342-351. PubMed ID: 28925802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell disease mice have cerebral oxidative stress and vascular and white matter abnormalities.
    Khaibullina A; Almeida LEF; Kamimura S; Zerfas PM; Smith ML; Vogel S; Wakim P; Vasconcelos OM; Quezado MM; Horkayne-Szakaly I; Quezado ZMN
    Blood Cells Mol Dis; 2021 Feb; 86():102493. PubMed ID: 32927249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients.
    Edwards O; Burris A; Lua J; Wilkie DJ; Ezenwa MO; Doré S
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.